Net loss of Samrat Pharmachem reported to Rs 0.59 crore in the quarter ended September 2025 as against net profit of Rs 2.66 crore during the previous quarter ended September 2024. Sales rose 12.40% to Rs 78.87 crore in the quarter ended September 2025 as against Rs 70.17 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 78.87 | 70.17 | 12 |
| OPM % | -0.46 | 4.80 | - |
| PBDT | -0.57 | 3.69 | PL |
| PBT | -0.75 | 3.52 | PL |
| NP | -0.59 | 2.66 | PL |
Powered by Capital Market - Live News